1. Home
  2. CRCT vs XNCR Comparison

CRCT vs XNCR Comparison

Compare CRCT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$4.07

Market Cap

857.6M

Sector

Industrials

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.04

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
XNCR
Founded
1969
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
857.6M
881.9M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
CRCT
XNCR
Price
$4.07
$12.04
Analyst Decision
Strong Sell
Buy
Analyst Count
2
10
Target Price
$3.50
$22.89
AVG Volume (30 Days)
621.5K
706.2K
Earning Date
03-03-2026
05-06-2026
Dividend Yield
23.28%
N/A
EPS Growth
20.69
65.36
EPS
0.35
N/A
Revenue
$708,780,000.00
$125,576,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$0.98
$11.88
P/E Ratio
$11.73
N/A
Revenue Growth
N/A
13.65
52 Week Low
$3.92
$6.92
52 Week High
$7.33
$18.69

Technical Indicators

Market Signals
Indicator
CRCT
XNCR
Relative Strength Index (RSI) 41.66 47.56
Support Level $3.92 $10.92
Resistance Level $4.83 $12.87
Average True Range (ATR) 0.15 0.71
MACD 0.01 0.04
Stochastic Oscillator 30.53 49.37

Price Performance

Historical Comparison
CRCT
XNCR

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: